Cellectis SA (CLLS)
3.92
-0.15
(-3.69%)
USD |
NASDAQ |
May 15, 16:00
3.99
+0.07
(+1.79%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 394.40M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 168.5% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 5.794 |
| Price to Book Value | 6.582 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.812 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 97.08% |
Profile
| Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France. |
| URL | http://www.cellectis.com |
| Investor Relations URL | https://www.cellectis.com/en/investors |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 11, 2026 (est.) |
| Last Earnings Release | May. 11, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France. |
| URL | http://www.cellectis.com |
| Investor Relations URL | https://www.cellectis.com/en/investors |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Aug. 11, 2026 (est.) |
| Last Earnings Release | May. 11, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |